LF
LifeTech Scientific Corporation
LFTSF · OTC
$0.23 +0.00% (+$0.00)
Market Cap ¥6.88B
P/E Ratio 30.93x
Div. Yield -
ROE 6.31%
Bulios Fair Price
$0.2
14.3% downside
Current Price
$0.23
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LFTSF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
25 /100
Expensive P/FCF 178.85x
P/E 30.93x
P/B 1.97x
Growth
35 /100
Stable FCF growth 35.83%
EPS growth 7.29%
Book val. growth 11.76%
Profitability
65 /100
Moderate Op. margin 14.29%
Gross margin 75.28%
FCF margin 2.95%
Quality
26 /100
Poor ROA 4.54%
ROIC 3.86%
Asset turnover 0.27x
Debt
100 /100
Low Int. coverage 106.29x
Debt/Equity 0.00x
Net debt/EBITDA -2.29x
Stability
75 /100
Stable EPS volatility 19.04%
Beta 0.31x
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LFTSF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Yue Hui Xie
Employees
1,245
Headquarters
Shenzhen